Coya TherapeuticsCOYA
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 26 institutions reported holding Coya Therapeutics Inc. (COYA) in their 13F filings, up 7 from Q3 2024. 7 opened new positions and 1 sold out. The largest holders were Greenlight Capital (DME Capital Management) ($9.4M), AIGH Capital Management LLC ($6.9M) and Vanguard Group Inc. ($4.8M). One famous investor held it David Einhorn (0.5% of Greenlight Capital (DME Capital Management)'s portfolio).
- Company
- Coya Therapeutics Inc.
- CUSIP
- 22407B108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.0M |
| Exits | 1 | $111K |
All 13F filers, Q3 2024 → Q4 2024: 1,156,965 shares bought and 28,307 shares sold, net +1,128,658 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Greenlight Capital (DME Capital Management) | 0.49% | Add +29.2% | 1,646,440 | $9.4M |
| AIGH Capital Management LLC | 2.59% | Add +85.0% | 1,201,152 | $6.9M |
| Vanguard Group Inc. | 0.00% | Reduce -0.6% | 840,471 | $4.8M |
| CM Management, LLC | 0.82% | Add +11.1% | 160,000 | $917K |
| Geode Capital Management, LLC | 0.00% | Add +5.8% | 150,576 | $863K |
| BlackRock, Inc. | 0.00% | Add +15.8% | 76,193 | $437K |
| NFSG Corp | 0.10% | New | 70,000 | $401K |
| State Street Corp. | 0.00% | Add +11.9% | 48,100 | $276K |
| UBS Group AG | 0.00% | New | 43,026 | $247K |
| Prelude Capital Management, LLC | 0.02% | No change | 35,770 | $205K |
| Susquehanna International Group, LLP | 0.00% | New | 30,735 | $176K |
| Northern Trust Corp. | 0.00% | Add +12.2% | 28,549 | $164K |
| GHP Investment Advisors, Inc. | 0.01% | No change | 26,171 | $150K |
| Royal Bank of Canada | 0.00% | Reduce -1.1% | 22,652 | $130K |
| Atom Investors LP | 0.01% | New | 14,276 | $82K |
| Mirador Capital Partners LP | 0.01% | Reduce -3.2% | 13,807 | $79K |
| Jane Street Group, LLC | 0.00% | New | 12,961 | $74K |
| XTX Topco Ltd | 0.01% | New | 10,299 | $59K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1005.7% | 5,252 | $30K |
| Osaic Holdings, Inc. | 0.00% | Add +78.3% | 3,342 | $19K |
| Morgan Stanley | 0.00% | Add +250.0% | 2,800 | $16K |
| SBI Securities Co., Ltd. | 0.00% | — | 761 | $4K |
| Jones Financial Companies LLLP | 0.00% | Reduce -90.1% | 600 | $3K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 500 | $3K |
| Bank of America Corp. | 0.00% | Add +8.5% | 115 | $659 |
| JPMorgan Chase & Co. | 0.00% | Add +3.2% | 32 | $183 |
"% of holder's portfolio" is COYA's weight in each manager's 13F, not the share of Coya Therapeutics Inc. the manager owns.